Clinical Trial: A Phase 1 Study of S-1117

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828393) titled 'A Phase 1 Study of S-1117' on Jan. 20.

Brief Summary: This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: S-1117

S-1117 via subcutaneous or intravenous administration.

OTHER: Placebo

Placebo via subcutaneous or intravenous administration.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Seismic Therapeutic AU Pty Ltd

Published by HT Digital Content Services with permission from Health Daily Digest....